MedTrace Logo

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects

NCT03198624 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-09-07

No results posted yet for this study

Summary

This is a single and multiple dose, parallel group study to assess safety and pharmacokinetics of oral HTL0018318 in healthy Japanese and Caucasian subjects.

Conditions

  • Safety Issues
  • Pharmacokinetics

Interventions

DRUG

HTL0018318

Part A single dose Part B five doses

DRUG

Placebo oral capsule

Part B only

Sponsors & Collaborators

  • Nxera Pharma UK Limited

    lead INDUSTRY

Principal Investigators

  • Jorg Taubel, MD FFPM · Richmond Pharmacology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-16
Primary Completion
2017-08-20
Completion
2017-08-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03198624 on ClinicalTrials.gov